CA - Bausch reports positive Phase 2 data for ulcerative colitis drug
2023-12-21 12:59:06 ET
More on Bausch Health Companies
- Bausch Health: $20bn Debt Is A Mighty Elephant In The Room
- Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript
- Bausch Health Companies Inc. 2023 Q3 - Results - Earnings Call Presentation
- Bausch Health swings to quarterly loss on goodwill impairments, higher expenses
- Bausch Health Companies Q3 2023 Earnings Preview
For further details see:
Bausch reports positive Phase 2 data for ulcerative colitis drug